Highly active engineered IgG3 antibodies against SARS-CoV-2
Sign Up to like & getrecommendations! Published in 2021 at "Proceedings of the National Academy of Sciences of the United States of America"
DOI: 10.1073/pnas.2107249118
Abstract: Monoclonal antibodies (mAbs) that efficiently neutralize SARS-CoV-2 have been developed at an unprecedented speed. Notwithstanding, there is a vague understanding of the various Ab functions induced beyond antigen binding by the heavy-chain constant domain. To… read more here.
Keywords: active engineered; igg3; igg3 antibodies; engineered igg3 ... See more keywords